0.04Open0.20Pre Close13 Volume483 Open Interest20.00Strike Price57.00Turnover3469.98%IV9.28%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0309Delta0.0822Gamma1831.00Leverage Ratio-42.4783Theta0.0000Rho56.49Eff Leverage0.0000Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet